http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#Head http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#assertion http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#provenance http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#pubinfo http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#assertion http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT http://www.w3.org/2000/01/rdf-schema#label significantly lower Charlson co - morbidity index 2.0 versus 3.0 , p 0.01 and higher temperature 38.7 C versus 38.2 C , p 0.004 than controls http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT-POSITION http://www.w3.org/2000/01/rdf-schema#label (22, 33) http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE http://www.w3.org/2000/01/rdf-schema#label had http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT http://www.w3.org/2000/01/rdf-schema#label Patients who received tocilizumab http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT-POSITION http://www.w3.org/2000/01/rdf-schema#label (22, 33) https://uts.nlm.nih.gov/uts/umls/concept/C0039476 http://www.w3.org/2000/01/rdf-schema#label temperature https://uts.nlm.nih.gov/uts/umls/concept/C1609165 http://wordnet-rdf.princeton.edu/lemma/have https://uts.nlm.nih.gov/uts/umls/concept/C0039476 https://uts.nlm.nih.gov/uts/umls/concept/C1609165 http://www.w3.org/2000/01/rdf-schema#label tocilizumab http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#provenance http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#_assertion http://www.w3.org/ns/prov#wasGeneratedBy S&T TWOC Project - version 4 http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#assertion http://www.w3.org/ns/prov#generatedAtTime 2023-06-12T11:58:35.527417 http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0003-4692-1377 http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.w3.org/2000/01/rdf-schema#label Patients who received tocilizumab had significantly lower Charlson co-morbidity index (2.0 versus 3.0, p = 0.01) and higher temperature (38.7 C versus 38.2 C, p = 0.004) than controls. http://www.w3.org/2000/01/rdf-schema#ABSTRACT-UID http://www.w3.org/2000/01/rdf-schema#label bu5l6v5l http://www.w3.org/2000/01/rdf-schema#TRIPLE-UID http://www.w3.org/2000/01/rdf-schema#label bu5l6v5l-TRIPLE-ABSTRACT-2 http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#pubinfo http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#sig http://purl.org/nanopub/x/hasPublicKey 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 http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#sig http://purl.org/nanopub/x/hasSignature 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 http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs http://purl.org/np/RAqUBoRIGBS2n865E_p1IelwtIsK12ivR_41KF9wleMCs http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0003-4692-1377